Use of Perioperative Pain Blocks In Urological Surgery
Pain, Postoperative, Nerve Block, Robotic Surgical Procedures
About this trial
This is an interventional supportive care trial for Pain, Postoperative focused on measuring Phase III, Randomized, Single blind, Single Center, Three arm, Non-inferiority
Eligibility Criteria
Inclusion Criteria:
- Age 18 years or older
- Undergoing Robotic Assisted Laparoscopic Partial Nephrectomy or Robotic Assisted Laparoscopic Prostatectomy
- Ability to understand and the willingness to sign a written informed consent.
Exclusion Criteria:
- Prior Partial Nephrectomy or Subtotal Prostatectomy Surgery (organ specific)
- Conversion to open surgery
- History of chronic pain
- History of opiate or alcohol dependence
- Allergies to local anesthetic
- Retroperitoneal surgery
- Single Port Surgery
Sites / Locations
- Mount Sinai Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Placebo Comparator
Active Comparator
Experimental
Placebo/Local Anesthesia
Ultrasound-guided transversus abdominus plane (UTAP) block
Laparoscopic-guided transversus abdominus plane (LTAP) block
Direct injection of 0.25% bupivacaine into surgical wounds
30mL of 0.25% bupivacaine will be administered to bilateral TAP using ultrasound guidance in prostatectomies. 40ml 0.25% bupivacaine unilateral will be administered in nephrectomy patients (weight based dosage permitting).
30mL of 0.25% bupivacaine will be administered to bilateral TAP using laparoscopic guidance in prostatectomies. 40ml 0.25% bupivacaine unilateral will be administered in nephrectomy patients (weight based dosage permitting).